Eyenovia Operating Margin from 2010 to 2024
| EYEN Stock | USD 0.11 0.02 19.05% |
Check Eyenovia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyenovia's main balance sheet or income statement drivers, such as Interest Income of 574.9 K, Depreciation And Amortization of 822.4 K or Interest Expense of 2.5 M, as well as many indicators such as Price To Sales Ratio of 21.3 K, Dividend Yield of 0.0 or PTB Ratio of 15.46. Eyenovia financial statements analysis is a perfect complement when working with Eyenovia Valuation or Volatility modules.
Eyenovia | Operating Margin |
Latest Eyenovia's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Eyenovia over the last few years. It is Eyenovia's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eyenovia's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (516.61) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Eyenovia Operating Margin Regression Statistics
| Arithmetic Mean | (1,458) | |
| Coefficient Of Variation | (206.14) | |
| Mean Deviation | 2,317 | |
| Median | (9.89) | |
| Standard Deviation | 3,005 | |
| Sample Variance | 9M | |
| Range | 7.7K | |
| R-Value | (0.70) | |
| Mean Square Error | 5M | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (467.60) | |
| Total Sum of Squares | 126.4M |
Eyenovia Operating Margin History
About Eyenovia Financial Statements
Eyenovia investors utilize fundamental indicators, such as Operating Margin, to predict how Eyenovia Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Eyenovia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Pair Trading with Eyenovia
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyenovia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will appreciate offsetting losses from the drop in the long position's value.Moving together with Eyenovia Stock
| 0.63 | VALN | Valneva SE ADR Downward Rally | PairCorr |
Moving against Eyenovia Stock
| 0.43 | VERA | Vera Therapeutics | PairCorr |
| 0.42 | VCEL | Vericel Corp Ord | PairCorr |
| 0.35 | SABSW | SAB Biotherapeutics | PairCorr |
The ability to find closely correlated positions to Eyenovia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyenovia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyenovia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyenovia to buy it.
The correlation of Eyenovia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyenovia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Eyenovia Correlation against competitors. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.001 | Quarterly Revenue Growth 4 | Return On Assets (0.93) | Return On Equity (9.15) |
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.